Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yuichi Kamikubo"'
Autor:
Naoki Ohkura1 n-ohkura@pharm.teikyo-u.ac.jp, Riyo Morimoto-Kamata1, Yuichi Kamikubo2, Yoshihisa Takahashi3, Katsutaka Oishi4,5,6
Publikováno v:
Drug Discoveries & Therapeutics. Oct2023, Vol. 17 Issue 5, p346-350. 5p.
Autor:
Yuichi KAMIKUBO
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 18:16-24
Autor:
Shuichi Horie, Hiroyuki Itabe, Tsutomu Hamuro, Naoki Ohkura, Sayuri Hiraishi, Tatsuya Takano, Juzo Matsuda, Yuichi Kamikubo
Publikováno v:
Antioxidants & Redox Signaling. 6:705-712
Tissue factor pathway inhibitor (TFPI) is a Kunitz-type protease inhibitor that inhibits the initial reactions of blood coagulation. In this study, we explored the nature of active components that reduce the anticoagulant activity of TFPI in oxidized
Autor:
Tadatoshi Yanagida, Yoshihisa Nagai, Yo Nakahara, Kosuke Kumeda, Hisao Kato, Saburo Hara, Yuichi Kamikubo, Ryo Takano, Xin-Yan Xu, Kaeko Kamei
Publikováno v:
International Journal of Biological Macromolecules. 30:151-160
Tissue factor pathway inhibitor (TFPI) is a heparin-binding protein involved in the extrinsic blood coagulation system. In order to elucidate the minimal size of heparin chain required for the interaction with TFPI, we prepared a series of heparin-de
Autor:
Kousuke Marutsuka, Nobuhiko Atsuchi, Hikaru Ueno, Akira Takeshita, Yuichi Kamikubo, Takahiro Nishida, Yujiro Asada
Publikováno v:
Circulation. 103:570-575
Background —Tissue factor pathway inhibitor (TFPI) is a physiological antagonist of TF. We tested whether a brief irrigation with TFPI protein (rTFPI) or TFPI gene transfer into injured arteries would suppress TF activity and reduce fibroproliferat
Autor:
Yujiro Asada, Hisataka Yasui, Akira Takeshita, Takahiro Nishida, Nobuhiko Atsuchi, Hikaru Ueno, Ryuji Kawano, Yuichi Kamikubo, Yo Nakahara
Publikováno v:
Circulation Research. 84:1446-1452
Abstract —The main cause of acute coronary syndrome may be recurrent thrombosis, which is initiated by the activation of the extrinsic coagulation pathway. Tissue factor (TF) pathway inhibitor (TFPI) efficiently inhibits an early step in this pathw
Autor:
Keiichi Enjyoji, Chiemi Hine, Yuichi Kamikubo, Hisao Kato, Katsuo Sueishi, Akira Takei, Shin Nakamura, Koichi Kokame
Publikováno v:
Journal of Biochemistry. 125:1039-1047
It has been reported that tissue factor pathway inhibitor (TFPI), a Kunitz-type protease inhibitor that regulates the extrinsic blood coagulation pathway, is not expressed in human, bovine, rabbit, or rat liver. Here, we found that TFPI is efficientl
Autor:
Yuichi Kamikubo, Akinobu Sumiyoshi, Kousuke Marutsuka, Kinta Hatakeyama, Yujiro Asada, Yuichiro Sato
Publikováno v:
Atherosclerosis. 133:213-219
Tissue factor (TF) is a transmembrane protein that serves as the major initiator of the blood coagulation cascade. The overexpression of TF antigen and mRNA has previously been reported in advanced atherosclerotic lesions. Recently TF procoagulant ac
Autor:
Tsutomu Hamuro, Akinobu Funatsu, Hiroshi Yonemura, Seiji Miyamoto, Hidehiro Fujimoto, Minako Ishihara, Yuichi Kamikubo, Keiichi Enjyoji, Takeo Abumiya, Toshiyuki Miyata, Shintaro Kamei, Hisao Kato
Publikováno v:
The Journal of Biochemistry. 115:708-714
Rhesus monkey cDNA for tissue factor pathway inhibitor (TFPI) was cloned by means of the reverse transcriptase-polymerase chain reaction, using liver mRNA, and its nucleotide sequence was determined by sequencing five independent clones. Monkey TFPI
Autor:
Yuichi Kamikubo1,2, Mendolicchio, G. Loredana3, Zampolli, Antonella1,2, Marchese, Patrizia1,2, Rothmeier, Andrea S.4, Orje, Jennifer Nagrampa1,2, Gale, Andrew J.1, Krishnaswamy, Sriram5, Gruber, András6, Østergaard, Henrik7, Petersen, Lars C.7, Ruf, Wolfram4,8 ruf@scripps.edu, Ruggeri, Zaverio M.1,2 ruggeri@scripps.edu
Publikováno v:
Blood. 10/5/2017, Vol. 130 Issue 14, p1661-1670. 10p.